Telehealth trial pairs pain care and alcohol counseling in HIV
People living with HIV often carry more than one behavior-linked burden at a time, and this protocol tackles two of the most clinically disruptive: unhealthy alcohol use and chronic pain. Both problems can erode adherence, complicate clinic engagement, and widen the gap between HIV diagnosis and durable viral suppression. The study tests an integrated telehealth model built to address both conditions together rather than as separate, siloed problems.
The intervention, called Motivational and Cognitive-Behavioral Management for Alcohol and Pain, or INTV, is designed for adults living with HIV who have unhealthy drinking and chronic pain. The protocol is notable for its remote structure, which matters because patients facing pain and alcohol-related harm often struggle to attend repeated in-person visits. By moving screening, counseling, and follow-up into a telehealth format, investigators are trying to lower a very practical barrier: the need to be physically present to receive help.
One sentence captures the clinical logic of the study: two common comorbidities are being treated as a shared therapeutic target instead of separate downstream consequences.
Remote enrollment and repeated symptom tracking shape the design
The trial plans to recruit 250 people living with HIV nationwide through online advertising. After remote informed consent and baseline assessment, participants will complete 15 days of ecological momentary assessment, a design choice that allows repeated capture of alcohol use, pain intensity, functioning, and behavior-change mechanisms in real time. This approach is more informative than a single baseline questionnaire because both pain and alcohol intake fluctuate across days, stressors, and social contexts.
Ecological momentary assessment also fits the biology and behavior of the problem. Alcohol use can worsen sleep, amplify pain sensitivity, and impair judgment around medication adherence, while persistent pain can drive self-medication with alcohol. In people living with HIV, those bidirectional effects can reverberate through the care continuum, affecting appointment attendance, treatment engagement, and the consistency of antiretroviral therapy. A design that measures symptoms repeatedly is better positioned to detect whether change happens in the spaces between clinic visits, where patients actually live their lives.
After the assessment run-in, participants will be randomized to INTV or a control condition. Both groups will meet with a health counselor by videoconference after randomization, which helps balance attention and contact across arms. The intervention arm will receive six additional sessions. The control arm will not receive those added sessions, allowing the study to isolate the effect of the integrated counseling package beyond the shared initial videoconference encounter.
Why chronic pain and alcohol use belong in the same intervention
Chronic pain is not a side issue in HIV care. It can interfere with mobility, sleep, mood, and self-management, and it often coexists with unhealthy drinking patterns that are used, at least in part, as a coping strategy. The protocol is built on the idea that treating pain and alcohol use separately may miss a key driver of persistence in both conditions. A counseling model that links motivational work with cognitive-behavioral strategies could plausibly reduce drinking by strengthening coping alternatives while also lowering pain-related distress and avoidance behaviors.
The intervention has a strong behavioral rationale. Motivational components can address ambivalence about alcohol change, while cognitive-behavioral methods can target pain catastrophizing, activity avoidance, and the habits that sustain both symptoms. In a population living with HIV, those mechanisms may be especially relevant because medical burden, stigma, and treatment fatigue can all shape daily decision-making. Telehealth adds reach, but the therapeutic content remains rooted in established behavioral principles.
At 3 and 6 months after baseline, participants will complete outcome assessments. The protocol specifies the hypothesis plainly: the integrated intervention will reduce unhealthy alcohol use and pain ratings relative to control. Because this is a protocol rather than a completed outcomes paper, no efficacy signal is yet available. The value lies in the trial architecture, which is aimed at determining whether one coordinated behavioral program can move two clinically important endpoints at once.
What the protocol could change for HIV care delivery
If the intervention proves effective, the bedside implications could be substantial. HIV clinics frequently encounter patients whose pain and drinking problems are treated in parallel, often by different clinicians with limited coordination. A single telehealth framework that addresses both may be easier to deliver at scale than separate specialty referrals, particularly for patients with transportation problems, limited local behavioral health access, or competing medical demands.
The use of remote delivery also makes the protocol relevant to real-world care models that continue to expand after the pandemic-era acceleration of telemedicine. Videoconferencing can extend counselor availability across geography and may improve access for people who avoid or cannot easily reach traditional clinic settings. For a population living with HIV, where continuity of care is central and missed visits can have cascading consequences, a remote intervention has a built-in pragmatic advantage.
Still, the study will need to show whether benefit persists beyond contact with counselors and whether symptom reduction translates into better engagement with HIV care. The protocol leaves those questions open, as it should. It is also limited by its reliance on remote self-report for several measures, a common and acceptable feature of behavioral research, but one that keeps the eventual interpretation anchored to patient-reported change rather than hard biomedical endpoints.
The study is registered at NCT05503173 and appears in Addiction Science & Clinical Practice as a 2024 protocol paper. Its central clinical question is straightforward: can an integrated telehealth behavioral program reduce two burdens that often reinforce one another in people living with HIV? The answer will depend on the randomized comparison now underway, with results pending from the planned 3- and 6-month follow-up assessments.
- • ClinicalTrials.gov Trial Protocol (NCT05503173): https://clinicaltrials.gov/study/NCT05503173
- • Journal Article DOI: https://doi.org/10.1186/s13722-024-00493-3